Weiss-Haug, A., Haraszti, R., Schroeder, J. C., Reuß, K., Merz, B., Rudat, S., Keppeler, H., Kramer, L., Mirovic, E., Faul, C., Pecher, A., Henes, J., Lutz, K., Hensen, L., Bethge, W., Schwartz, F., Lengerke, C. (2025). Defining a high-risk population for CAR-T-cell therapy: The impact of clonal hematopoiesis and pre-existing neutropenia on severe outcomes in patients treated for malignant and non-malignant conditions. Blood. https://doi.org/10.1182/blood-2025-5942